• Behavioral Health
  • Clinical Insights
  • Treatment

Webinar: Medication-assisted Treatment: Trends and Outcomes

Dec 20th, 2022

For consumers living with opioid use disorder (OUD), medication-assisted treatment (MAT) has become the gold standard of treatment. In a new webinar, Genoa Healthcare Director of Operations Megan Garrity, PharmD, and Pharmacist Ryan Grant, PharmD, share how MAT programs can impact patients and clinics.

Frequently Asked Questions:

  • For more information about Narcan and Sublocade, please reach out to your Genoa Healthcare pharmacy team. You can also reach out directly to Indivior for more information on Sublocade by calling their Medical Information Line at 1-877-782-6966.
  • For questions on SAMSHA, please click here.

Studies referred to in this webinar:

Let’s talk

Reliable, full-service pharmacy care

Interested in learning more about how Medication-assisted treatment can help support your consumers? Genoa can help. Contact us today and we’ll be in touch.

"*" indicates required fields

Name*
City
State
This field is for validation purposes and should be left unchanged.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Partnering with Genoa
CMS reporting now required: 4 ways Genoa can help

By Reena Neumann, PharmD, MBA Since January 1, 2024, the Centers for Medicare & Medicaid Services (CMS) has required that clinics provide outcomes data reporting to secure federal funding through...

  • Consumer Stories
  • People-first Pharmacy Care
For people in crisis, access to a safe place is critical

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...

  • Consumer Stories
  • People-first Pharmacy Care
Genoa pharmacist saves the life of someone she’s never met

Having witnessed the effects of the opioid crisis in her community firsthand, Genoa Healthcare® Pharmacist Kristen Pyland had prepared for the day she’d need to rush into action to aid...

Partner with Genoa
  • Behavioral Health
  • Clinical Insights
  • Treatment
Brixadi®: 3 things to know about the buprenorphine treatment option

Staying on top of new medication therapy options for your consumers living with opioid use disorder (OUD) can be difficult. Learn how the new FDA-approved medication, Brixadi®, can help support...